← Leaderboards
Jennifer Eileen Adair
Fred Hutchinson Cancer Center
$3,488,178
Attributed
$6,976,355
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$6,976,355 · 3
By mechanism
R01$6,707,690 · 2
D43$268,665 · 1
Top collaborators
- Justin J Taylor8 shared
- Cissy Kityo1 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Hans-Peter Kiem$98,160,227
- Lawrence Corey$859,232,520
- Christopher W Peterson$4,927,751
- Roland Bruno Walter$12,142,218
- Stanley R Riddell$31,084,866
Others in their field
Other Rising Stars on “Novel Strategies”
- Mari Ostendorf · University Of Washington$51,931,230
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Alaina J Harkness · Current Innovation, Nfp$13,724,091
- Thomas K Karikari · Wake Forest University Health Sciences$12,972,426
- Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
Research focus
Novel StrategiesGene TherapySuccessGenetic EngineeringBlood CellsAntigensGenetically Modified CellsHematopoietic Stem CellsImmunityEngineeringGenesGeneticImmunologyCell TypeClustered Regularly Interspaced Short Palindromic RepeatsCost EffectiveCellsCollaborationsAntibody FormationAntibodiesB-LymphocytesEnsureGene DeliveryImmune
Grant awards (9)
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles$830,363
R01 · FY2025 · AI · contact PI
Targeted genetic engineering of B cells to induce protective antibody responses to pathogens$618,943
R01 · FY2025 · AI · contact PI
Leveraging North-South Partnerships toAdvance Cell and Gene Therapy for HIV Research Training Capacity in Uganda (C and GT-Uganda)$268,665
D43 · FY2025 · TW
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles$895,395
R01 · FY2024 · AI · contact PI
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens$855,174
R01 · FY2024 · AI · contact PI
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles$907,227
R01 · FY2023 · AI · contact PI
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens$859,486
R01 · FY2023 · AI · contact PI
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles$877,927
R01 · FY2022 · AI · contact PI
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens$863,175
R01 · FY2022 · AI · contact PI